135 related articles for article (PubMed ID: 25896003)
41. AptaBlocks: Designing RNA complexes and accelerating RNA-based drug delivery systems.
Wang Y; Hoinka J; Liang Y; Adamus T; Swiderski P; Przytycka TM
Nucleic Acids Res; 2018 Sep; 46(16):8133-8142. PubMed ID: 29986050
[TBL] [Abstract][Full Text] [Related]
42. Synthetic Polymer Hybridization with DNA and RNA Directs Nanoparticle Loading, Silencing Delivery, and Aptamer Function.
Zhou Z; Xia X; Bong D
J Am Chem Soc; 2015 Jul; 137(28):8920-3. PubMed ID: 26138550
[TBL] [Abstract][Full Text] [Related]
43. Chitosan Nanoparticles for SiRNA Delivery In Vitro.
Ragelle H; Vanvarenberg K; Vandermeulen G; Préat V
Methods Mol Biol; 2016; 1364():143-50. PubMed ID: 26472448
[TBL] [Abstract][Full Text] [Related]
44. Target-specific gene silencing of layer-by-layer assembled gold-cysteamine/siRNA/PEI/HA nanocomplex.
Lee MY; Park SJ; Park K; Kim KS; Lee H; Hahn SK
ACS Nano; 2011 Aug; 5(8):6138-47. PubMed ID: 21739990
[TBL] [Abstract][Full Text] [Related]
45. Aptamer for imaging and therapeutic targeting of brain tumor glioblastoma.
Delač M; Motaln H; Ulrich H; Lah TT
Cytometry A; 2015 Sep; 87(9):806-16. PubMed ID: 26189784
[TBL] [Abstract][Full Text] [Related]
46. [Advance in the study of targeting delivery system for siRNA mediated by aptamers].
Wang XL; Wang QQ; Song HF
Yao Xue Xue Bao; 2012 Jul; 47(7):850-5. PubMed ID: 22993847
[TBL] [Abstract][Full Text] [Related]
47. Assessment of drug delivery and anticancer potentials of nanoparticles-loaded siRNA targeting STAT3 in lung cancer, in vitro and in vivo.
Das J; Das S; Paul A; Samadder A; Bhattacharyya SS; Khuda-Bukhsh AR
Toxicol Lett; 2014 Mar; 225(3):454-66. PubMed ID: 24440344
[TBL] [Abstract][Full Text] [Related]
48. Design and Preparation of Aptamer-siRNA Chimeras (AsiCs) for Targeted Cancer Therapy.
Kruspe S; Giangrande PH
Methods Mol Biol; 2017; 1632():175-186. PubMed ID: 28730439
[TBL] [Abstract][Full Text] [Related]
49. Specific Targeting of STAT3 in B Cells Suppresses Progression of B Cell Lymphoma.
Wang L; Zhou M; Kong X; Wu S; Ding C; Hu X; Guo H; Yan J
Int J Mol Sci; 2023 Sep; 24(17):. PubMed ID: 37686472
[TBL] [Abstract][Full Text] [Related]
50. Nanoparticle-based strategy for personalized B-cell lymphoma therapy.
Martucci NM; Migliaccio N; Ruggiero I; Albano F; Calì G; Romano S; Terracciano M; Rea I; Arcari P; Lamberti A
Int J Nanomedicine; 2016; 11():6089-6101. PubMed ID: 27895482
[TBL] [Abstract][Full Text] [Related]
51. [Inhibitory effect of silencing STAT3 gene with short hairpin RNA mediated by polyamidoamine dendrimers on growth of prostate cancer].
Zhao WM; Xiu YC; Xu Y; Wang YM; Cheng ZK; Yu Q; Kong DL
Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):575-9. PubMed ID: 18210874
[TBL] [Abstract][Full Text] [Related]
52. Therapeutic effects of signal transducer and activator of transcription 3 siRNA on human breast cancer in xenograft mice.
Yang Z; Cai JH; Xie SJ; Li GX; Song WQ; Yan QH; Yan L; Zhang F
Chin Med J (Engl); 2011 Jun; 124(12):1854-61. PubMed ID: 21740845
[TBL] [Abstract][Full Text] [Related]
53. Recent advances in siRNA delivery.
Sarisozen C; Salzano G; Torchilin VP
Biomol Concepts; 2015 Dec; 6(5-6):321-41. PubMed ID: 26609865
[TBL] [Abstract][Full Text] [Related]
54. Gold nanoparticle-assisted delivery of small, highly structured RNA into the nuclei of human cells.
Ryou SM; Kim JM; Yeom JH; Hyun S; Kim S; Han MS; Kim SW; Bae J; Rhee S; Lee K
Biochem Biophys Res Commun; 2011 Dec; 416(1-2):178-83. PubMed ID: 22093830
[TBL] [Abstract][Full Text] [Related]
55. A Hitchhiker's guide to HIV.
Yan A; Ellington A
Mol Ther; 2008 Aug; 16(8):1356-8. PubMed ID: 18660800
[No Abstract] [Full Text] [Related]
56. Advances in aptamer-mediated targeted delivery system for cancer treatment.
He S; Du Y; Tao H; Duan H
Int J Biol Macromol; 2023 May; 238():124173. PubMed ID: 36965552
[TBL] [Abstract][Full Text] [Related]
57. Therapeutic delivery of siRNA silencing HIF-1 alpha with micellar nanoparticles inhibits hypoxic tumor growth.
Liu XQ; Xiong MH; Shu XT; Tang RZ; Wang J
Mol Pharm; 2012 Oct; 9(10):2863-74. PubMed ID: 22924580
[TBL] [Abstract][Full Text] [Related]
58. Folate receptor-targeted RNAi nanoparticles for silencing STAT3 in tumor-associated macrophages and tumor cells.
Chen J; Dou Y; Tang Y; Zhang X
Nanomedicine; 2020 Apr; 25():102173. PubMed ID: 32084593
[TBL] [Abstract][Full Text] [Related]
59. [Therapeutic siRNAs and non-viral systems for their delivery].
Glebova KV; Marakhonov AV; Baranova AV; Skoblov MIu
Mol Biol (Mosk); 2012; 46(3):371-86. PubMed ID: 22888628
[TBL] [Abstract][Full Text] [Related]
60. A highly entangled polymeric nanoconstruct assembled by siRNA and its reduction-triggered siRNA release for gene silencing.
Namgung R; Kim WJ
Small; 2012 Oct; 8(20):3209-19. PubMed ID: 22961919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
